TipRanks
Insulet (CH:GOV)
:GOV

Compare Insulet (GOV) vs. Competitors

1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Insulet
―
CHF8.08B
26.08
10 Buy
10 Hold
0 Sell
Moderate Buy
Abbott Laboratories
$116.13
$176.19B
32.74
-23.20%
14 Buy
0 Hold
0 Sell
Strong Buy
Dexcom
$88.96
$32.42B
33.17
31.94%
19 Buy
1 Hold
0 Sell
Strong Buy
Medtronic
$92.02
$117.59B
22.48
-3.69%
10 Buy
9 Hold
0 Sell
Moderate Buy
Tandem Diabetes Care
$21.37
$1.14B
-17.71
17.50%
8 Buy
7 Hold
0 Sell
Moderate Buy
Beta Bionics, Inc.
$19.07
$963.48M
-10.63
-15.07%
11 Buy
4 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CH:GOV
Insulet
―
―
―
ABT
Abbott Laboratories
101.82
-26.59
-20.71%
DXCM
Dexcom
85.92
20.72
31.78%
MDT
Medtronic
91.93
-0.58
-0.63%
TNDM
Tandem Diabetes Care
16.45
2.58
18.60%
BBNX
Beta Bionics, Inc.
17.86
-4.29
-19.37%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts